Search research articles
Contact Us
Filters
Showing results (71-80 of 106) with videos related to
Page
of 11
Sort By:
International Journal of Molecular Sciences
|
July 12, 2025
A Tourette Syndrome/ADHD-like Phenotype Results from Postnatal Disruption of CB<sub>1</sub> and CB<sub>2</sub> Receptor Signalling
Victoria Gorberg, Tamar Harpaz, Emilya Natali Shamir, et al.
British Journal of Pharmacology
|
August 28, 2019
Δ<sup>8</sup> -Tetrahydrocannabivarin has potent anti-nicotine effects in several rodent models of nicotine dependence
Zheng-Xiong Xi, Pretal Muldoon, Xiao-Fei Wang, et al.
Journal of Medicinal Chemistry
|
April 14, 2009
Conformationally constrained fatty acid ethanolamides as cannabinoid and vanilloid receptor probes
Giovanni Appendino, Alessia Ligresti, Alberto Minassi, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
July 19, 2017
The In Vivo Effects of the CB<sub>1</sub>-Positive Allosteric Modulator GAT229 on Intraocular Pressure in Ocular Normotensive and Hypertensive Mice
Elizabeth A Cairns, Anna-Maria Szczesniak, Alex J Straiker, et al.
Journal of Medicinal Chemistry
|
June 14, 2002
Synthesis and structure-activity relationships of amide and hydrazide analogues of the cannabinoid CB(1) receptor antagonist N-(piperidinyl)- 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716)
Maria Elena Y Francisco, Herbert H Seltzman, Anne F Gilliam, et al.
Organic & Biomolecular Chemistry
|
February 18, 2017
Synthesis, radio-synthesis and in vitro evaluation of terminally fluorinated derivatives of HU-210 and HU-211 as novel candidate PET tracers
Chiara Zanato, Alessia Pelagalli, Katie F M Marwick, et al.
European Journal of Medicinal Chemistry
|
December 28, 2020
Variously substituted 2-oxopyridine derivatives: Extending the structure-activity relationships for allosteric modulation of the cannabinoid CB2 receptor
Francesca Gado, Kawthar A Mohamed, Serena Meini, et al.
Pediatric Research
|
August 6, 2008
Neuroprotective effects of the nonpsychoactive cannabinoid cannabidiol in hypoxic-ischemic newborn piglets
Francisco J Alvarez, Hector Lafuente, M Carmen Rey-Santano, et al.
British Journal of Pharmacology
|
July 2, 2010
The plant cannabinoid Delta9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice
Daniele Bolognini, Barbara Costa, Sabatino Maione, et al.
European Journal of Medicinal Chemistry
|
October 23, 2012
Investigations on the 4-quinolone-3-carboxylic acid motif. 6. Synthesis and pharmacological evaluation of 7-substituted quinolone-3-carboxamide derivatives as high affinity ligands for cannabinoid receptors
Serena Pasquini, Maria De Rosa, Alessia Ligresti, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 106) with videos related to
Sort By:
Page
of 11
International Journal of Molecular Sciences
|
July 12, 2025
A Tourette Syndrome/ADHD-like Phenotype Results from Postnatal Disruption of CB<sub>1</sub> and CB<sub>2</sub> Receptor Signalling
Victoria Gorberg, Tamar Harpaz, Emilya Natali Shamir, et al.
British Journal of Pharmacology
|
August 28, 2019
Δ<sup>8</sup> -Tetrahydrocannabivarin has potent anti-nicotine effects in several rodent models of nicotine dependence
Zheng-Xiong Xi, Pretal Muldoon, Xiao-Fei Wang, et al.
Journal of Medicinal Chemistry
|
April 14, 2009
Conformationally constrained fatty acid ethanolamides as cannabinoid and vanilloid receptor probes
Giovanni Appendino, Alessia Ligresti, Alberto Minassi, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
July 19, 2017
The In Vivo Effects of the CB<sub>1</sub>-Positive Allosteric Modulator GAT229 on Intraocular Pressure in Ocular Normotensive and Hypertensive Mice
Elizabeth A Cairns, Anna-Maria Szczesniak, Alex J Straiker, et al.
Journal of Medicinal Chemistry
|
June 14, 2002
Synthesis and structure-activity relationships of amide and hydrazide analogues of the cannabinoid CB(1) receptor antagonist N-(piperidinyl)- 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716)
Maria Elena Y Francisco, Herbert H Seltzman, Anne F Gilliam, et al.
Organic & Biomolecular Chemistry
|
February 18, 2017
Synthesis, radio-synthesis and in vitro evaluation of terminally fluorinated derivatives of HU-210 and HU-211 as novel candidate PET tracers
Chiara Zanato, Alessia Pelagalli, Katie F M Marwick, et al.
European Journal of Medicinal Chemistry
|
December 28, 2020
Variously substituted 2-oxopyridine derivatives: Extending the structure-activity relationships for allosteric modulation of the cannabinoid CB2 receptor
Francesca Gado, Kawthar A Mohamed, Serena Meini, et al.
Pediatric Research
|
August 6, 2008
Neuroprotective effects of the nonpsychoactive cannabinoid cannabidiol in hypoxic-ischemic newborn piglets
Francisco J Alvarez, Hector Lafuente, M Carmen Rey-Santano, et al.
British Journal of Pharmacology
|
July 2, 2010
The plant cannabinoid Delta9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice
Daniele Bolognini, Barbara Costa, Sabatino Maione, et al.
European Journal of Medicinal Chemistry
|
October 23, 2012
Investigations on the 4-quinolone-3-carboxylic acid motif. 6. Synthesis and pharmacological evaluation of 7-substituted quinolone-3-carboxamide derivatives as high affinity ligands for cannabinoid receptors
Serena Pasquini, Maria De Rosa, Alessia Ligresti, et al.
Page
of 11